Catheter Ablation for Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy: Electrophysiological

Shuyu Jin1, Mengmeng Li1, Chenxi Jiang1

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.

PubMed

Insights

Catheter ablation for hypertrophic cardiomyopathy ventricular tachycardia (HCM-VT) primarily involves 3D re-entrant circuits. Success depends on identifying the VT origin and its intramural extent for effective ablation.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Catheter ablation for hypertrophic cardiomyopathy ventricular tachycardia (HCM-VT) is understudied, with limited data on VT distribution and electrophysiological characteristics.
  • Existing research primarily focuses on feasibility and safety, leaving VT substrate and circuit properties insufficiently understood.

Purpose of the Study:

  • To comprehensively characterize the site-specific electrophysiological properties of ventricular tachycardia (VT) in hypertrophic cardiomyopathy (HCM).
  • To evaluate catheter ablation outcomes for HCM-VT based on detailed substrate and circuit analysis.

Main Methods:

  • Inclusion of 32 patients with HCM-VT undergoing catheter ablation.
  • Utilized combined endocardial and epicardial mapping to identify and analyze arrhythmogenic substrates and re-entrant circuits.
  • Induced and mapped 28 VTs across 25 patients to understand circuit mechanisms.

Main Results:

  • The majority of VTs (25/28) were scar-mediated re-entries, predominantly located in the left ventricular (LV) lateral wall, apical aneurysm, and superior basal regions.
  • Incomplete activation sequences were observed, indicating complex re-entrant pathways with mid-myocardial involvement.
  • Long-term VT-free survival varied by VT origin, with superior basal regions and septum showing 0% survival, while LV lateral wall and apical aneurysm had higher rates (73.3% and 83.3% respectively) after initial ablation.

Conclusions:

  • HCM-VT commonly presents as three-dimensional re-entrant circuits with significant mid-myocardial involvement.
  • Successful catheter ablation is contingent upon accurately identifying the VT re-entrant circuit's origin and its extent of intramural penetration.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
165
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
107
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
120